TLDR Spironolactone helps regrow hair in women with hair loss.
The document discusses the use of spironolactone as an antiandrogen in the treatment of female pattern hair loss (FPHL). FPHL is a common cause of hair loss in women, and spironolactone has been shown to be effective in treating FPHL by blocking androgen receptors and reducing the production of androgens. The standard dose used is 100 to 200 mg daily, and lower doses of 50 to 75 mg have also been shown to stabilize hair loss in some women. A study investigated 80 women with biopsy-proven FPHL, and 44% of women had clearly visible hair regrowth after 12 months of spironolactone therapy. However, further work is required to establish the precise utility of spironolactone in FPHL and to determine the optimal dose.View this study on pubmed.ncbi.nlm.nih.gov →
Aromatase gene variation may increase female hair loss risk.
Spironolactone successfully treated hair loss in a 9-year-old girl.
Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.
Spironolactone and minoxidil together effectively treat female pattern hair loss.
Hair loss severity relates to increased miniaturization in female pattern hair loss.
Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.
Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.
Women with female pattern hair loss often underestimate how severe it is.
5% and 2% minoxidil solutions effectively promote hair growth and reduce hair loss, with 5% being slightly more effective but having more side effects.
Minoxidil boosts hair growth by opening potassium channels and increasing cell activity.
All three treatments reduce hirsutism, but spironolactone works best long-term.
Balding men seen as older, less attractive, and less confident.
Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.
Hair loss can significantly affect a person's self-esteem and body image, especially in young people, those who value their looks highly, and women.
Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.
FPHL affects hair density and diameter, causing visible hair loss in older women.
Hair loss in women is common, starts in late 20s, and affects 30% of women over 50.
Finasteride doesn't effectively treat hair loss in postmenopausal women.
"Christmas tree" pattern helps diagnose female hair loss.
Finasteride safely and effectively treats male pattern hair loss, but may cause reversible sexual issues and harm male fetuses.
People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.
Hair loss affects women's mental health more than men's, causing anxiety, low self-esteem, and social insecurity.
Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.
"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.
Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.
Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.
Spironolactone helps regrow hair in women with hair loss.